SEARCH

SEARCH BY CITATION

References

  • Babcock, R.B., Dumper, C.W. & Scharfman, W.B. (1976) Heparin-induced immune thrombocytopenia. New England Journal of Medicine, 295, 237241.
  • Becker, T., Panzer, S., Maas, D., Kiefel, V., Sprenger, R., Kirschbaum, M. & Mueller-Eckhardt, C. (1985) High-dose intravenous immunoglobulin for post-transfusion purpura. British Journal of Haematology, 61, 149155.
  • Bernstein, S.H., Nademanee, A.P., Vose, J.M., Tricot, G., Fay, J.W., Negrin, R.S., DiPersio, J., Rondon, G., Champlin, R., Barnett, M.J., Cornetta, K., Herzig, G.P., Vaughan, W., Geils, Jr, G.Keating, A. Messner, H. Wolff, S.N. Miller, K.B. Linker, C. Cairo, M. Hellmann, S. Ashby, M. Stryker, S. & Nash, R.A. (1998) A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplanation. Blood, 91, 35093517.
  • Bishop, J.F. McGrath, K. Wolf, M.M. Matthews, J.P. De Luise, T. Holdsworth, R. Yuen, K. Veale, M. Whiteside, M.G., Cooper, I.A. & Szer, J. (1988) Clinical factors influencing the efficacy of pooled platelet transfusions. Blood, 71, 383387.
  • Bowden, R.A. Slichter, S.J. Sayers, M. Weisdorf, D. Cays, M. Schoch, G. Banaji, M. Haake, R. Welk, K. Fisher, L. McCullough, J. & Miller, W. (1995) A comparison of filtered leucokyte-reduced and cytomegalovirus-negative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood, 86, 35983603.
  • Brand, A. (2001) Alloimmune platelet refractoriness: incidence declines, unsolved problems persist. Transfusion, 41, 724726.
  • British Committee for Standards in Haematology (1988) Guidelines for transfusion of massive blood loss. Clinical and Laboratory Haematology, 10, 265273.
  • British Committee for Standards in Haematology (1992) Guidelines for platelet transfusions. Transfusion Medicine, 2, 311318.
  • British Committee for Standards in Haematology (1996) Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfusion Medicine, 6, 261271.
  • British Committee for Standards in Haematology (1997) Guidelines for the administration of blood products: transfusion of infants and neonates. Transfusion Medicine, 7, 248.
  • British Committee for Standards in Haematology (1998) Guidelines on the clinical use of leucocyte-depleted blood components. Transfusion Medicine, 8, 5971.
  • British Committee for Standards in Haematology (1999) Guidelines for the administration of blood and blood components and the management of transfused patients. Transfusion Medicine, 9, 227238.
  • British Committee for Standards in Haematology (2003a) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. British Journal of Haematology, 120, 574596.
  • British Committee for Standards in Haematology (2003b) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. British Journal of Haematology, 120, 556573.
  • Cimo, P.L., Moake, J.L., Weinger, R.S., Ben-Menachem, Y. & Khalil, K.G. (1979) Heparin-induced thrombocytopenia: association with a platelet-aggregating factor and arterial thromboses. American Journal of Hematology, 6, 125133.
  • Consensus Conference on Platelet Transfusion (1998) Synopsis of background papers and consensus statement. British Journal of Haematology, 101, 609617.
  • Crookston, K.P., Reiner, A.P., Cooper, L.J.N., Sacher, R.A., Blajchman, M.A. & Heddle, N.M. (2000) RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion, 40, 801812.
  • Development Task Force of the College of American Pathologists (1994) Practice parameter for the use of fresh frozen plasma, cryoprecipitate and platelets. Journal of the American Medical Association, 271, 777781.
  • Doughty, H.A., Murphy, M.F., Metcalfe, P., Rohatiner, A.Z.S., Lister, T.A. & Waters, A.H. (1994) Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sanguinis, 66, 200205.
  • Eder, A.F. & Manno, C.S. (2001) Does red-cell T activation matter? British Journal of Haematology, 114, 2530.
  • Freireich, E.J. (2000) Supportive care for patients with blood disorders. British Journal of Haematology, 111, 6877.
  • George, J.N. & Shattil, S.J. (1991) The clinical importance of acquired abnormalities of platelet function. New England Journal of Medicine, 324, 2739.
  • George, J.N., Caen, J.P. & Nurden, A.T. (1990) Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood, 75, 13831395.
  • Gil-Fernandez, J.J., Alegre, A., Fernandes-Villalta, M.J., Pinilla, I., Gomez Garcia, V., Martinez, C., Tomas, J.F., Arranz, R., Figuera, A., Camara, R. & Fernandez-Ranada, J.M. (1996) Clinical results of a stringent policy on prophylactic platelet transfusion: non randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplantation, 18, 931935.
  • Gmur, J., Burger, J., Schanz, U., Fehr, J. & Schaffner, A. (1991) Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet, 388, 12231226.
  • Goldman, M. & Delage, G. (1995) The role of leukodepletion in the control of transfusion-transmitted disease. Transfusion Medicine Reviews, 9, 919.
  • Gordon, L.I., Kwaan, H.C. & Rossi, E.C. (1987) Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy. Seminars in Hematology, 24, 194201.
  • Harkness, D.R., Byrnes, J.J., Lian, E.C.Y., Williams, W.D. & Hensley, G.T. (1981) Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. Journal of the American Medical Association, 246, 19311933.
  • Heaton, W.A., Rebulla, P., Pappalettera, M. & Dzik, W.H. (1997) A comparative analysis of different methods for routine blood component preparation. Transfusion Medicine Reviews, 11, 116129.
  • Heckman, K.D., Weiner, G.J., Davis, C.S., Strauss, R.G., Jones, M.P. & Burns, C.P. (1997) Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukaemia: 10,000/μl versus 20,000/μl. Journal of Clinical Oncology, 15, 11431149.
  • Higby, D.J., Cohen, E., Holland, J.F. & Sinks, L. (1974) The prophylactic treatment of thrombocytopenic leukaemic patients with platelets: a double blind study. Transfusion, 14, 440446.
  • Hiippala, S. (1998) Replacement of massive blood loss. Vox Sanguinis, 74, 399407.
  • Hillyer, C.D., Emmens, R.K., Zago-Novaretti, M. & Berkman, E.M. (1994) Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion, 34, 929934.
  • Holohan, T.V., Terasaki, P.I. & Deisseroth, A.B. (1981) Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood, 58, 122128.
  • Horsey, P.J. (1997) Multiple trauma and massive transfusion. Anaesthesia, 52, 10271029.
  • Hunt, B.J. (1998) Indications for therapeutic platelet transfusions. Blood Reviews, 12, 227233.
  • Kiefel, V., Konig, C., Kroll, H. & Santoso, S. (2001) Platelet antibodies in transfused patients. Transfusion, 41, 766770.
  • Kurz, M., Knobl, P., Kalhs, P., Greinix, H.T., Hocker, P. & Panzer, S. (2001) Platelet-reactive HLA antibodies associated with low post-transfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test. Transfusion, 41, 771774.
  • Lapaucis, A., Brown, J., Costello, B., Delage, G., Freedman, J., Hume, H., King, S., Kleinman, S., Mazzulli, T. & Wells, G. (2001) Prevention of post-transfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion, 41, 560569.
  • Letsky, E.A. & Greaves, M. (1996) Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. British Journal of Haematology, 95, 2126.
  • Mallett, S.V. & Cox, D.J.A. (1992) Thromboelastography. British Journal of Anaesthesia, 69, 307313.
  • Menitove, J.E. (2002) Immunoprophylaxis for D– patients receiving platelet transfusions from D– donors? Transfusion, 42, 136138.
  • Mueller-Eckhardt, C., Kiefel, V. & Grubert, A. (1989) High-dose IgG treatment for neonatal alloimmune thrombocytopenia. Blut, 59, 145146.
  • Murphy, M.F. & Allen, D.L. (1997) Provision of platelets for severe neonatal alloimmune thrombocytopenia. British Journal of Haematology, 97, 931932.
  • National Blood Service Transfusion Medicine Clinical Policies Group (2000) Guidelines on ABO and RhD compatibility in relation to platelet transfusions. Blood Matters, 5, 69.
  • National Confidential Enquiry into Peri-operative Deaths (2001) Changing the Way We Operate. The 2001 Report of the National Confidential Enquiry into Peri-operative Deaths. WWW document. URL: http://www.ncepod.org.uk/01sum.pdf.
  • National Institutes of Health Consensus Conference (1987) Platelet transfusion therapy. Journal of the American Medical Association, 257, 17771780.
  • Nevo, S., Swan, V., Enger, C., Wojno, K.J., Bitton, R., Shabooti, M., Fuller, A.K., Jones, R.J., Braine, H.G. & Vogelsang, G.B. (1998) Acute bleeding after bone marrow transplantation (BMT): incidence and effect on survival: a quantitative analysis in 1,402 patients. Blood, 91, 14691477.
  • Novotny, V.M.J. (1999) Prevention and management of platelet transfusion refractoriness. Vox Sanguinis, 76, 113.
  • O'Connell, B.A., Lee, E.J. & Schiffer, C.A. (1988) The value of 10-minute post-transfusion platelet counts. Transfusion, 26, 6667.
  • Pamphilon, D.H., Rider, J.R., Barbara, J.A.J. & Williamson, L.M. (1999) Prevention of transfusion-transmitted cytomegalovirus infection. Transfusion Medicine, 9, 115123.
  • Patel, I.P., Ambinder, E., Holland, J.F. & Aldedort, L.M. (1978) In vitro and in vivo comparison of single-donor platelets and multiple-donor pooled platelet transfusions in leukemic patients. Transfusion, 18, 116119.
  • Phekoo, K.J., Hambley, H., Win, N., Schey, S.A.R., Carr, R. & Murphy, M.F. (1997) Audit of practice in platelet refractoriness. Vox Sanguinis, 73, 8186.
  • Poon, M-C., Demers, C., Jobin, F. & Wu, J.W.Y. (1999) Recombinant VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood, 94, 39513953.
  • Ramasethu, J. & Luban, N.L.C. (2001) T activation. British Journal of Haematology, 112, 259263.
  • Rebulla, P., Finazzi, G., Marangoni, F., Avvisati, G., Gugliotta, L., Tognoni, G., Barbui, T., Mandelli, F. & Sirchia, G. for the Gruppo Itanliano Malattie Ematologiche Maligne dell'Adulto (1997) The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. New England Journal of Medicine, 337, 18701875.
  • Ronghe, M.D., Foot, A.B.M., Cornish, J.M., Steward, C.G., Carrington, D., Goulden, N., Marks, D.I., Oakhill, A. & Pamphilon, D.H. (2002) The impact of transfusion of leucodepleted platelet concentrates on cytiomegalovirus disease after allogeneic stem cell transplantation. British Journal of Haematology, 118, 11241127.
  • Roy, A.J., Jaffe, N. & Djerassi, I. (1973) Prophylactic platelet transfusions in children with acute leukaemia. Transfusion, 13, 283290.
  • Sayers, M.H., Anderson, K.C., Goodnough, L.T., Kurtz, S.R., Lane, T.A., Pisciotto, P. & Silberstein, L.E. (1992) Reducing the risk for transfusion-transmitted cytomegalovirus infection. Annals of Internal Medicine, 116, 5562.
  • Schiffer, C.A., Anderson, K.C., Bennett, C.L., Bernstein, S., Elting, L.S., Goldsmith, M., Goldstein, M., Hume, H., McCullough, J.J., McIntyre, R.E., Powell, B.L., Rainey, J.M., Rowley, S.D., Rebulla, P., Troner, M.B. & Wagnon, A.H. for the American Society of Clinical Oncology (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 19, 15191538.
  • Shpilberg, O., Blumenthal, R., Sofer, O., Katz, Y., Chetrit, A., Ramot, B., Eldor, A. & Ben-Bassat, I. (1995) A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukaemia. Leukemia and Lymphoma, 19, 141144.
  • Simon, T.L., Akl, B.F. & Murphy, W. (1984) Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Annals of Thoracic Surgery, 37, 359364.
  • Slichter, S.J. (1980) Controversies in platelet transfusion therapy. Annual Reviews of Medicine, 31, 509540.
  • Stainsby, D., MacLennan, S. & Hamilton, P.J. (2000) Management of massive blood loss: a template guideline. British Journal of Anaesthesia, 85, 487491.
  • The Serious Hazards of Transfusion Steering Group (2002) Serious Hazards of Transfusion: Annual Report 2001–2002 Available as a downloadable document from: http://www.shotuk.org.
  • The Trial to Reduce Alloimmunization to Platelets Study Group (1997) Leukocyte reduction and UV-B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusion. New England Journal of Medicine, 337, 18611869.
  • Turner, V.S., Hawker, R.J., Mitchell, S.G. & Seymour Mead, A.M. (1994) Paired in vitro and in vivo comparison of apheresis and recovered platelet concentrates stored for five days. Journal of Clinical Apheresis, 9, 189194.
  • UK Blood Transfusion Services/National Institute for Biological Standards and Controls (UKBTS/NIBSC) (2002) Guidelines for the Blood Transfusion Service, 6th edn. The Stationery Office, UK.
  • Wandt, H., Frank, M., Ehnigner, G., Schneider, G., Brack, N., Daoud, A., Fackler-Shwalbe, I., Fischer, J., Gackle, R., Geer, T., Harms, P., Loffler, B., Ohl, S., Otremba, B., Raab, M., Schonrock-Nabulsi, P., Strobel, G., Winter, R. & Link, H. (1998) Safety and cost effectiveness of a 10 × 109/l trigger for prophylactic platelet transfusions compared with the traditional 20 × 109/l trigger: a prospective comparative trial in 105 patients with acute myeloid leukaemia. Blood, 91, 36013606.
  • Warkentin, T.E., Chong, B.H. & Greinacher, A. (1998) Heparin-induced thrombocytopenia: towards consensus. Thrombosis and Haemostasis, 79, 17.